The Jakarta Post
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search results
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search resultsSecond vaccine booster significantly lowers COVID death rate
The country's largest healthcare provider, Clalit Health Services, said the 40-day study included more than half a million people aged 60 to 100.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
A health worker prepare to give the Pfizer COVID-19 coronavirus vaccine at a makeshift clinic at the Aceh Museum in Banda Aceh on Jan. 17, 2022. (AFP/Chaideer Mahyuddin)
S
enior citizens who received a second booster of the Pfizer–BioNTech COVID-19 vaccination had a 78 percent lower mortality rate from the disease than those who got one only, a study from Israel showed on Sunday.
The country's largest healthcare provider, Clalit Health Services, said the 40-day study included more than half a million people aged 60 to 100.
Some 58 percent of participants had received a second booster - or two shots in addition to the basic two-shot regimen. The remainder had received only one booster. Researchers recorded 92 deaths among the first group and 232 deaths among the second, smaller group.
"The main conclusion is that the second booster is lifesaving," said Ronen Arbel, Health Outcomes Researcher at Clalit and Sapir College.
The report was issued as a preprint and has not been peer-reviewed. The research excluded people who received rival Moderna's vaccine and those who had taken oral anti-COVID therapy.
Israeli health officials have put out a number of studies on vaccine efficacy throughout the pandemic that have impacted policymaking in other countries.
More from The Weekender
Farewell, good breast
A cancer diagnosis brings more than the fear of illness. It raises difficult questions about how to protect those we love while revealing unexpected reserves of tenderness and resilience.
Siapa Anda? Mengapa Anda?
What begins as a small grammatical curiosity becomes a larger question about language, culture and the way we understand ourselves in relation to others - and, ultimately, about what we risk losing in a world increasingly impatient with reflection, ambiguity and the humanities.
A passport to the kingdom of the sick
A breast cancer diagnosis, a journey to the kingdom of the sick and a determination to describe what lies there without metaphor, euphemism or the word “fight.”
